Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Probiotic and prebiotic supplements for digestive health after chronic spinal cord injury

Official title: The Effect of Probiotic and Prebiotic Supplementation on Gastrointestinal Health in Individuals With Chronic Spinal Cord Injury: A Randomized Controlled Crossover Trial

Run by Swiss Paraplegic Research, Nottwil · NCT06870331 · Data updated 2026-11-12

This trial will test whether taking a probiotic or a prebiotic can improve digestive symptoms, gut microbiome balance, inflammation, and transit time in adults with long-term spinal cord injury.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorSwiss Paraplegic Research, Nottwil
Research network
Locations1 site (Nottwil, Canton of Lucerne)
StatusRecruiting
StartedAugust 11, 2025
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedOctober 3, 2025
Trial IDNCT06870331 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with chronic (>1 year) spinal cord injury (para- or tetraplegia, AIS A–D) who have significant gastrointestinal complaints (GIQLI score below 110) and can attend the study center are ideal candidates.

Probably not a fit

People who recently used antibiotics, made major diet changes within four weeks, have active inflammatory bowel disease or other significant gastrointestinal disorders, or are on certain immunomodulating medications are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center crossover interventional trial enrolls adults with chronic spinal cord injury who report significant gastrointestinal complaints. Participants will take either a probiotic or a prebiotic daily for eight weeks, have a four-week washout, then take the other supplement for eight weeks, with four study visits for measurements. Outcomes include gastrointestinal symptom scores, gut microbiome composition, inflammatory serum markers, and gastrointestinal transit time. The study is conducted at Swiss Paraplegic Research in Nottwil and excludes recent antibiotic use or major recent dietary changes.

Why it matters

Potential benefit: If successful, the supplements could reduce gastrointestinal symptoms, favorably change the gut microbiome, lower inflammatory markers, and improve bowel transit for people with chronic spinal cord injury.

How similar studies have gone: Some prior studies in other populations show probiotics or prebiotics can alter the microbiome and improve gut symptoms, but evidence specific to chronic spinal cord injury is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (at screening):

* Age: ≥ 18 years
* Sex: male and female.
* Chronic SCI (\>1 year post-injury)
* Individuals with para- and tetraplegia (American Spinal Cord Injury (ASIA) Impairment Scale (AIS) score A-D)
* Having significant gastrointestinal complaints, indicated with "yes" at screening and by a GIQLI questionnaire score below 110 at baseline
* Signed written informed consent

Exclusion Criteria (at screening):

* Antibiotic use within the last four weeks before starting the study
* Major dietary changes within the last four weeks before starting the study, such as initiating a vegan or ketogenic diet
* Presence of clinically relevant medical conditions, including Crohn's disease, diagnosed eating or gastrointestinal disorders, assessed on an individual basis
* Intake of significant concomitant medication, including immunomodulating therapy, mesalazines, or steroids, assessed on an individual basis
* Concurrent participation in other clinical trials investigating or potentially affecting GI health
* Insufficient German language skills to follow the study procedures
* Pregnancy (anamnestic)

Where it's running

  • Swiss Paraplegic Research
    Nottwil, Canton of Lucerne, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.